Silo Pharma Inc
NASDAQ:SILO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
S
|
Silo Pharma Inc
NASDAQ:SILO
|
5.1m USD |
Loading...
|
|
| FR |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
269.9B EUR |
Loading...
|
|
| FR |
|
Hermes International SCA
PAR:RMS
|
214.8B EUR |
Loading...
|
|
| KR |
|
SBW
KRX:102280
|
235.5T KRW |
Loading...
|
|
| FR |
|
EssilorLuxottica SA
PAR:EL
|
104.7B EUR |
Loading...
|
|
| CH |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
92.2B CHF |
Loading...
|
|
| FR |
|
Christian Dior SE
PAR:CDI
|
93.3B EUR |
Loading...
|
|
| IN |
|
Titan Company Ltd
NSE:TITAN
|
3.9T INR |
Loading...
|
|
| FR |
|
Kering SA
PAR:KER
|
35.1B EUR |
Loading...
|
|
| DE |
|
Adidas AG
XETRA:ADS
|
28.2B EUR |
Loading...
|
|
| US |
|
Tapestry Inc
NYSE:TPR
|
31.5B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Silo Pharma Inc
Glance View
Silo Pharma, Inc. engages in the development of streetwear apparel brands. The company is headquartered in Englewood Cliffs, New Jersey. The company went IPO on 2012-01-05. The firm is focused on merging traditional therapeutics with psychedelic research for people suffering from indications, including depression, post-traumatic stress disorder (PTSD), Parkinson's disease and other neurological disorders. The firm is focused on the use of psilocybin as a therapeutic. Psilocybin is considered a serotonergic hallucinogen and is an ingredient in some species of mushrooms.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Silo Pharma Inc is 65.3%, which is below its 3-year median of 92.3%.
Over the last 3 years, Silo Pharma Inc’s Gross Margin has decreased from 100% to 65.3%. During this period, it reached a low of 65.3% on Sep 30, 2025 and a high of 100% on Sep 30, 2023.
